• Category Current Studies

XACT – III A randomized controlled trial (RCT) to evaluate a scalable active case-finding intervention for TB using a point-of-care molecular tool (Gene Xpert)

To evaluate the multi-country efficacy and feasibility of tuberculosis active case-finding using a portable battery-powered molecular diagnostic platform (Xpert) installed within a low-cost scalable mobile mini-clinic using a Nissan panel van staffed by 3 health care workers.

Participant recruitment is ongoing.

Start: November 2021 – runs for 48 months

Funded by EDCTP/DFID